Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial
Alex Luedtke, Youyi Fong, Lars van der Laan, Fei Heng et autres
1 citationiScience
Mathieu Le Gars
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
64Publications signalées
6161Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approachesImmune responses and vaccinationsVaccine Coverage and Hesitancy
Publications récentes
The epigenomic landscape of bronchial epithelial cells reveals the establishment of trained immunity
Jeanne Bigot, Rachel Legendre, Juliette Hamroune, Sébastien Jacques et autres
12 citationsGenes and Immunity
Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy
Gloria Aguilar, Gabriela Tapia-Calle, Cynthia Robinson, Benoît Baron et autres
2 citationsHuman Vaccines & Immunotherapeutics
Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial
Nina Hertoghs, Sanne Roels, Matthias Brückner, Jerald Sadoff et autres
9 citationsEBioMedicine
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Leah Andrews, M. Elizabeth Halloran, Lars van der Laan, Yunda Huang et autres
6 citationsJAMA Network Open
The epigenomic landscape of bronchial epithelial cells reveals the establishment of trained immunity
Jeanne Bigot, Rachel Legendre, Juliette Hamroune, Sébastien Jacques et autres
2 citationsbioRxiv (Cold Spring Harbor Laboratory)
P-100. Durable immune response induced by self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidates against variants of concern (VOC) in HIV-negative and people living with HIV (PLWH) populations in South Africa, irrespective of prior SARS-CoV-2 vaccination
Atul Nagare, Élizabeth Martin, Anthonet Koen, Essack Mitha et autres
0 citationsOpen Forum Infectious Diseases
Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial
Jelena Tica, Veronica V. Rezelj, Benoît Baron, Vitalija van Paassen et autres
3 citationsHuman Vaccines & Immunotherapeutics
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial
Gabriela Tapia-Calle, Gloria Aguilar, Nathalie Vaissière, Carla Truyers et autres
4 citationsEClinicalMedicine
Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical Trial
Veronica V. Rezelj, Fred Paddenburg, Marie Enajite Diegbe, Julius Nangosyah et autres
1 citationVaccines
Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16–17 Years of Age
Javier Ruiz‐Guiñazú, Mathieu Le Gars, Vicky Cárdenas, Nathalie Vaissière et autres
0 citationsJournal of the Pediatric Infectious Diseases Society
Modelling antibody dynamics in humans after different Ad26.COV2.S vaccination schemes
Anna Dari, Juan José Pérez Ruixo, Mathieu Le Gars, Frank Struyf et autres
0 citationsBritish Journal of Clinical Pharmacology
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.